Sell Astrazeneca Pharma India Ltd with a target of Rs 600: Prakash Gaba

"Astrazeneca Pharma India Ltd is a ‘SELL’ call with a target of Rs 600 and a stop loss of Rs 700."

| May 24, 2013, 11.34 AM IST

In a chat with ET Now, Prakash Gaba, CFT, prakashgaba.com, gives his overview on Astrazeneca Pharma India Ltd.

ET Now: What is your call on Astrazeneca Pharma India Ltd?

Prakash Gaba: Astrazeneca Pharma India Ltd is a ‘SELL’ call with a target of Rs 600 and a stop loss of Rs 700.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!